The label includes a Boxed Warning describing the risk of hepatotoxicity associated with APAP. Most cases of liver injury were associated with APAP doses >4000mg daily and often involved >1 APAP-containing product.
Compared to placebo, selective serotonin reuptake inhibitors (SSRIs) were associated with a significantly higher risk of headache (risk ratio [RR] 1.06, 95% CI: 1.00 to 1.13; P =.045).
Both strengths of Sumavel DosePro have now been discontinued.
Lannett announced that the FDA has approved Sumatriptan Nasal Spray, the generic version of GlaxoSmithKline’s Imitrex Nasal Spray.
Compared to acetaminophen monotherapy, the combination of acetylsalicylic acid, caffeine and acetaminophen is more effective in treating episodic tension-type headaches, says a new study.
